期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations 被引量:3
1
作者 Chao Qin Li-Jiang Sun +11 位作者 Li Cui Qiang Cao Jian Zhu Pu Li Gui-Ming Zhang Xin Mao Peng-Fei Shao mei-lin wang Zheng-Dong Zhang Min Gu Wei Zhang Chang-Jun Yin 《Asian Journal of Andrology》 SCIE CAS CSCD 2013年第4期550-557,I0011,共9页
This study was designed to evaluate whether the revised 2010 Tumour Node Metastasis (TNM) staging system could lead to a more accurate prediction of the prognosis of renal cell carcinoma (RCC) patients. A total of... This study was designed to evaluate whether the revised 2010 Tumour Node Metastasis (TNM) staging system could lead to a more accurate prediction of the prognosis of renal cell carcinoma (RCC) patients. A total of 1216 patients who had undergone radical nephrectomy or partial nephrectomy for RCC from 2003 to 2011 were enrolled. All of the patients had pathologically confirmed clear cell RCC (ccRCC). All cases were staged by both the 2002 and 2010 TNM staging systems after pathological review, and survival data were collected. Univariate and multivariate Cox regression models were used to evaluate cancer-specific survival (CSS) and progression-free survival (PFS) after surgery. Continuous variables, such as age and tumour diameter, were calculated as mean values and standard deviations (s.d.) or as median values. Survival was calculated by the Kaplan-Meier method, and the log-rank test assessed differences between groups. Statistically significant differences in CSS and PFS were noted among patients in T3 subgroups using the new 2010 staging system. Therefore, the revised 2010 TNM staging system can lead to a more accurate prediction of the prognosis of ccRCC patients. However, when using the revised 2010 staging system, we found that more than 92% of patients (288/313) with T3 tumours were staged in the T3a subgroup, and their survival data were not significantly different from those of patients with T2b tumours. In addition, T2 subclassification failed to independently predict survival in RCC patients. 展开更多
关键词 kidney neoplasm PROGNOSIS renal cell carcinoma TNM stage
下载PDF
A bi-As-capped and tetra-V-substituted arsenomolybdate:synthesis,structure,capacitive and electrocatalytic properties
2
作者 Shuang-Hong Ge Li-Ping Cui +4 位作者 Kai Yu mei-lin wang Chun-Mei wang Lian-Xin Guo Bai-Bin Zhou 《Tungsten》 EI CSCD 2023年第2期270-276,共7页
A bi-As-capped and tetra-V-substituted arsenomolybdate(Hbib)_(2)(biyb)_(3)[As^(Ⅲ)_(2)As^(Ⅴ)Mo^(Ⅵ)8V^(Ⅴ)_(4)O_(40)]_(2)·H_(2)O(1)(bib=1.4-Bis(imidazoly)butane;biyb=1,4-bis(imidazol-1-ylmethyl)benzene)has been ... A bi-As-capped and tetra-V-substituted arsenomolybdate(Hbib)_(2)(biyb)_(3)[As^(Ⅲ)_(2)As^(Ⅴ)Mo^(Ⅵ)8V^(Ⅴ)_(4)O_(40)]_(2)·H_(2)O(1)(bib=1.4-Bis(imidazoly)butane;biyb=1,4-bis(imidazol-1-ylmethyl)benzene)has been constructed through hydrothermal methods and characterized by conventional method.Compound 1 is a tetra-V substituted{AsMo^(Ⅵ)_(8)V^(Ⅴ)_(4)O_(4)}polyanions capped by two AsⅢcations at two symmetrical ditch in{AsO_(4)}rectangular pyramid geometry.It exhibits higher specific capacitance,capacitance retention,and electrocatalytic activities for oxidizing ascorbic acid and reducing peroxide hydrogen. 展开更多
关键词 Arsenomolybdate Crystal structure Hydrothermal synthesis Capacitive performence Electrocatalytic nronerty
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部